137 related articles for article (PubMed ID: 37926541)
1. Crystalline Light Chain Casts and Hypercalcemia Induced Acute Kidney Injury: A Rare Presentation of Multiple Myeloma.
Nishigaito T; Mitsumoto K; Katsunuma R; Hirai Y; Yamashita C; Mizumoto A; Uzu T
Intern Med; 2024 Jun; 63(12):1751-1755. PubMed ID: 37926541
[TBL] [Abstract][Full Text] [Related]
2. Crystalline appearance in light chain cast nephropathy is associated with higher early mortality in patients with newly diagnosed multiple myeloma.
Lin ZS; Zhang X; Yu XJ; Wang S; Wang SX; Dong YJ; Zhou FD; Zhao MH
Int Immunopharmacol; 2021 Sep; 98():107875. PubMed ID: 34146864
[TBL] [Abstract][Full Text] [Related]
3. Successful renal recovery from multiple myeloma-associated crystalline light chain cast nephropathy and accompanying acute kidney injury with early use of bortezomib-based therapy: a case report and literature review.
Miki K; Shimamura Y; Maeda T; Moniwa N; Ogawa Y; Shimizu T; Hayashi T; Sakai H; Takizawa H
CEN Case Rep; 2023 Feb; 12(1):56-62. PubMed ID: 35854043
[TBL] [Abstract][Full Text] [Related]
4. Two kinds of rare light chain cast nephropathy caused by multiple myeloma: case reports and literature review.
Sun LJ; Dong HR; Xu XY; Wang GQ; Cheng H; Chen YP
BMC Nephrol; 2021 Jan; 22(1):42. PubMed ID: 33509125
[TBL] [Abstract][Full Text] [Related]
5. Coincidental crystalline light chain cast nephropathy, light chain proximal tubulopathy, and urine crystallopathy: A case report and review of the literature
.
Lerner G; Moradi S; Cohen-Bucay A; Chen H; Sanchorawala V; Gordon CE; Henderson JM
Clin Nephrol; 2020 Apr; 93(4):203-208. PubMed ID: 31907143
[TBL] [Abstract][Full Text] [Related]
6. Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold.
Manohar S; Nasr SH; Leung N
Curr Hematol Malig Rep; 2018 Jun; 13(3):220-226. PubMed ID: 29725932
[TBL] [Abstract][Full Text] [Related]
7. Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy.
Matthai SM; Alexander S; Jacob S; Duhli N; David VG; Varughese S
Indian J Pathol Microbiol; 2020; 63(3):463-466. PubMed ID: 32769341
[TBL] [Abstract][Full Text] [Related]
8. Myeloma light chain cast nephropathy, a review.
Sathick IJ; Drosou ME; Leung N
J Nephrol; 2019 Apr; 32(2):189-198. PubMed ID: 29730782
[TBL] [Abstract][Full Text] [Related]
9. Clinic-pathological characteristics of rare tubulointerstitial diseases.
Shi K; Yuan S; Huang Y; Li Z; Wang C; Liu H; Sun L; Liu F; Zhu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1365-1374. PubMed ID: 36411687
[TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma with acute light chain cast nephropathy.
Leung N; Rajkumar SV
Blood Cancer J; 2023 Mar; 13(1):46. PubMed ID: 36990996
[TBL] [Abstract][Full Text] [Related]
11. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
Wu CK; Yang AH; Lai HC; Lin BS
BMC Nephrol; 2017 May; 18(1):170. PubMed ID: 28545410
[TBL] [Abstract][Full Text] [Related]
12. Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma.
Bouchet A; Teuma C; Nouvier M; Rousset P; Javaugue V; Lazareth A; Lombard C; Isaac S; Fouque D
Am J Kidney Dis; 2019 Nov; 74(5):700-702. PubMed ID: 31155325
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
Sens F; Chaintreuil D; Jolivot A; Guebre-Egziabher F; Robinson P; Karlin L; Bridoux F; Juillard L
Am J Nephrol; 2017; 46(5):355-363. PubMed ID: 29017155
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study.
Royal V; Leung N; Troyanov S; Nasr SH; Écotière L; LeBlanc R; Adam BA; Angioi A; Alexander MP; Asunis AM; Barreca A; Bianco P; Cohen C; Drosou ME; Fatima H; Fenoglio R; Gougeon F; Goujon JM; Herrera GA; Knebelmann B; Lepori N; Maletta F; Manso R; Motwani SS; Pani A; Rabant M; Rennke HG; Rocatello D; Rosenblum F; Sanders PW; Santos A; Soto K; Sis B; Touchard G; Venner CP; Bridoux F
Blood; 2020 May; 135(21):1833-1846. PubMed ID: 32160635
[TBL] [Abstract][Full Text] [Related]
15. High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.
Hutchison CA; Cockwell P; Moroz V; Bradwell AR; Fifer L; Gillmore JD; Jesky MD; Storr M; Wessels J; Winearls CG; Weisel K; Heyne N; Cook M
Lancet Haematol; 2019 Apr; 6(4):e217-e228. PubMed ID: 30872075
[TBL] [Abstract][Full Text] [Related]
16. Management of acute kidney injury in symptomatic multiple myeloma.
Bridoux F; Leung N; Belmouaz M; Royal V; Ronco P; Nasr SH; Fermand JP;
Kidney Int; 2021 Mar; 99(3):570-580. PubMed ID: 33440212
[TBL] [Abstract][Full Text] [Related]
17. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
Finkel KW; Cohen EP; Shirali A; Abudayyeh A;
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2273-2279. PubMed ID: 27526708
[TBL] [Abstract][Full Text] [Related]
18. The light at the end of the tunnel: an unusual case of acute kidney injury in a pediatric patient: Answers.
Steinberg M; Gaut JP; Hmiel SP; Kakajiwala A
Pediatr Nephrol; 2018 Dec; 33(12):2269-2273. PubMed ID: 29523959
[TBL] [Abstract][Full Text] [Related]
19. A novel option for reducing free light chains in myeloma kidney: supra-hemodiafiltration with endogenous reinfusion (HFR).
Pasquali S; Iannuzzella F; Corradini M; Mattei S; Bovino A; Stefani A; Palladino G; Caiazzo M
J Nephrol; 2015 Apr; 28(2):251-4. PubMed ID: 25149172
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of light chain cast nephropathy through immunostaining of the urine: Perfecting the "liquid biopsy".
Huidobro E JP; Anghileri F; Méndez GP; Barrera G; Reyes R; Sepúlveda RA
Clin Nephrol; 2021 Oct; 96(4):239-242. PubMed ID: 34190682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
